IQ

Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

FMED vs TEKY: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to TEKY's +0.2%; 0% of their weight is in the same names.

askIQ about this page

askIQ about FMED and TEKY

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $61m on Jun 30, 2026 for Lazard Next Gen Technologies ETF.

FMED on its own →TEKY on its own →
At a glance
21.8%
FMED in the S&P 500
50.9%
TEKY in the S&P 500
+27.4%
FMED total return, 1 year
+0.2%
TEKY total return, 1 year
FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500
78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 33% of the fund · 72 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

TEKY · 1 year to Nov 4, 2026 49% of its weight is outside the S&P 500
49% of its weight is outside the S&P 50051% of TEKY's weight is in S&P 500 companies and 49% is outside the index. Holdings as of Jun 30, 2026.51%49%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 78% · top ten 39% of the fund · 48 holdings as filed for Jun 30, 2026 · Nasdaq-100: 45% in49% of its weight is outside the S&P 50051% of TEKY's weight is in S&P 500 companies and 49% is outside the index. Holdings as of Jun 30, 2026.51%49%in the S&P 500outside the S&P 500active share 78% · Nasdaq-100: 45% in

51% of TEKY's weight is in S&P 500 companies and 49% is outside the index. Holdings as of Jun 30, 2026.

Pair scorecard

Both cost 0.50% a year; their one-year returns differ by 27.2 points.

Points (pts) are percentage points.

FMED vs TEKY: Holdings Overlap & Returns
MeasureFMEDTEKY
Return
Total return, 1 year+27.4%+0.2%
Drawdown
Below its all-time high17.5%, high on Oct 6, 2026
Against its benchmark
What it tracksBroad innovation and megatrendsBroad innovation and megatrends
Its benchmark, total return, 1 year+15.2%
Against its benchmark, 1 yearbehind by 15.0 pts
Cost and size
Expense ratio0.50%0.50%
Net assets, FMED as of Sep 30, 2026 and TEKY as of Jun 30, 2026$52m$61m
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, FMED and TEKY hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first FMED TEKY
Only in one fund ↓
Only in FMED
10X GENOMICS INC 5.19%
THERMO FISHER SCIENTIFIC INC 3.83%
DANAHER CORP 3.73%
NATERA INC 3.30%
ARGENX SE 3.20%
LIFESTANCE HEALTH GROUP INC 3.00%
REVOLUTION MEDICINES INC 2.87%
ILLUMINA INC 2.82%
Only in TEKY
SK hynix Inc 5.65%
Alphabet Inc 5.19%
NVIDIA Corp 4.88%
Taiwan Semiconductor Manufacturing Co Ltd 3.96%
Amazon.com Inc 3.67%
Advanced Micro Devices Inc 3.65%
Broadcom Inc 3.34%
Applied Materials Inc 3.15%
Check overlap with more funds →

Window by window

Window by window: FMED vs TEKY: Holdings Overlap & Returns
Total returnvs its benchmark
WindowFMEDTEKYFMEDTEKY
3 months+14.9%−11.8%not measured−11.2 pts vs URTH
6 months+31.2%−7.9%not measured−12.2 pts vs URTH
1 year+27.4%+0.2%not measured−15.0 pts vs URTH
3 years+57.8%–not measured–
Since launchNot the same days: FMED Jun 2023 · TEKY Apr 2025+31.7%+60.3%not measured+6.3 pts vs URTH

– means no data for this window. Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies TEKY Lazard Next Gen Technologies ETF · Holds 48 stocks in broad innovation and megatrends, 51% of its weight in S&P 500 companies
Issuer Fidelity Lazard
Theme Broad innovation and megatrends Broad innovation and megatrends
In the S&P 500 21.8% 50.9%
Active share vs the S&P 500 97.5% 77.7%
In the Nasdaq-100 5.1% 44.6%
Holdings 72 48
Top ten, share of the fund 33.2% 39.2%
Expense ratio 0.50% 0.50%
Fee for the differing part 0.51% 0.64%
Total return, 1 year +27.4% +0.2%
vs its benchmark not measured −15.0 pts vs URTH
Below its high −0.9% −17.5%
Net assets, FMED as of Sep 30, 2026 and TEKY as of Jun 30, 2026 $52m $61m

As of Nov 4, 2026. Source: ETFIQ.

0% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

TEKY

By weight, 51% of TEKY's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 78%. The top ten holdings are 39% of the fund across 48 positions, as filed for Jun 30, 2026. Over the year to Nov 4, 2026 the fund returned +0.2% with distributions reinvested against +15.2% for its benchmark, the MSCI World Index, so a holder was behind by 15.0 pts. It sits 17.5% below its all-time high of Oct 6, 2026.

Questions people ask

Do FMED and TEKY hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or TEKY?
FMED has 22% of its weight in S&P 500 names and TEKY has 51%, so FMED differs more from the index.
Which is cheaper, FMED or TEKY?
FMED and TEKY both charge 0.50% a year, so neither is cheaper. Fees come from each fund's prospectus.
Other comparisons
FMED vs CARZFMED vs GDOCFMED vs TNXTFMED vs DTRETEKY vs THMZTEKY vs AOTGTEKY vs TNXTTEKY vs BULD
Where to next
All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →FMED on its own →TEKY on its own →FMED dividend history →FMED holdings →TEKY dividend history →TEKY holdings →Method →Standards and sources →
Sources and dates
FMED filings on SEC EDGAR ↗
FMED prospectus with the expense ratio (SEC) ↗
Fidelity website ↗
TEKY filings on SEC EDGAR ↗
TEKY prospectus with the expense ratio (SEC) ↗
Lazard website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, FMED against TEKY, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-teky

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.